Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR/Regional Partnership Program/Operating Grants

University of Saskatchewan

$132,144.00

Molecular mechanism of the human copper-transporting ATPases

FY 2008-09

Summary
Copper is required for the activity of many enzymes involved in respiration, neuron function, formation of connective tissue, endocrine processes, and radical detoxification in the human body. Wilson disease ATPase and Menkes disease ATPase regulate copper concentration in the cell and deliver copper to biosynthetic pathways. These proteins are targets of many mutations that cause severe metabolic disorders. Importantly, Wilson and Menkes ATPases are involved in cancer resistance to platinum- based chemotherapeutic drugs. To understand the critical steps in the activity cycle of the copper ATPases, we will investigate the structure, molecular motions and interactions of the isolated domains, or functional modules, of the Wilson and Menkes proteins using multidimensional Nuclear Magnetic Resonance (NMR), a technique uniquely suited for studying protein structure and dynamics in solution. We will trace the sequence of molecular events involved in substrate binding by copper-transporting ATPases and analyze the structural basis of several frequent disease causing mutations. This work is expected to improve the understanding of an important class of transport proteins and provide a new insight into the molecular basis of the disorders of copper metabolism. Structures of the individual domains of Wilson and Menkes ATPase will facilitate design of the new inhibitors and modulators of these enzymes, which may help to overcome certain types of drug resistance in cancer.
Program
CIHR/Regional Partnership Program/Operating Grants
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
177538
Name
Dmitriev Oleg Y
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Saskatchewan Health Research Foundation
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Biochemistry & Molecular Biology - A
Projecttitle
Molecular mechanism of the human copper-transporting ATPases
Programtype2
Operating Grants
Orgnameinp2
University of Saskatchewan
Cihramount2
$132,144
Cihrequipment2
$0
Programname2
CIHR/Regional Partnership Program/Operating Grants
Keyworddelim
Atpase; Copper Transport; Menkes Disease; Nmr; Protein Stucture; Wilson Disease
Abstract
Copper is required for the activity of many enzymes involved in respiration, neuron function, formation of connective tissue, endocrine processes, and radical detoxification in the human body. Wilson disease ATPase and Menkes disease ATPase regulate copper concentration in the cell and deliver copper to biosynthetic pathways. These proteins are targets of many mutations that cause severe metabolic disorders. Importantly, Wilson and Menkes ATPases are involved in cancer resistance to platinum- based chemotherapeutic drugs. To understand the critical steps in the activity cycle of the copper ATPases, we will investigate the structure, molecular motions and interactions of the isolated domains, or functional modules, of the Wilson and Menkes proteins using multidimensional Nuclear Magnetic Resonance (NMR), a technique uniquely suited for studying protein structure and dynamics in solution. We will trace the sequence of molecular events involved in substrate binding by copper-transporting ATPases and analyze the structural basis of several frequent disease causing mutations. This work is expected to improve the understanding of an important class of transport proteins and provide a new insight into the molecular basis of the disorders of copper metabolism. Structures of the individual domains of Wilson and Menkes ATPase will facilitate design of the new inhibitors and modulators of these enzymes, which may help to overcome certain types of drug resistance in cancer.
Competitiondate
200809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Dmitriev, Oleg Y; Delbaere, Louis T
Approvedterm
2 ans 0 mois
Cihrcontribution2
SPIR~ $132,144~ $0~